Gastroparesis Drugs Market to Grow by USD 1.42 Billion , Diabetes Burden Boosts Growth, AI Impact on Market Trends - Technavio
| SUHIX Fund | USD 46.65 0.13 0.28% |
Slightly above 55% of Deutsche Health's investor base is interested to short. The analysis of overall sentiment of trading Deutsche Health And mutual fund suggests that many investors are impartial at this time. Deutsche Health's investing sentiment can be driven by a variety of factors including economic data, Deutsche Health's earnings reports, geopolitical events, and overall market trends.
Deutsche |
Report with market evolution powered by AI - The global gastroparesis drugs market size is estimated to grow by USD 1.42 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 3.69 percent during the forecast period. Rising global burden of diabetes is driving market growth, with a trend towards increasing growth opportunities in emerging markets. However, stringent regulatory guidelines poses a challenge.Key market players include Abbott Laboratories, AbbVie Inc.,
Read at finance.yahoo.com
 |
Deutsche Health Fundamental Analysis
We analyze Deutsche Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deutsche Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deutsche Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Deutsche Health is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Deutsche Health And Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Deutsche Health mutual fund to make a market-neutral strategy. Peer analysis of Deutsche Health could also be used in its relative valuation, which is a method of valuing Deutsche Health by comparing valuation metrics with similar companies.
Peers
Deutsche Health Related Equities
| KTCCX | Deutsche Science | 0.75 | ||||
| KTCSX | Deutsche Science | 0.71 | ||||
| KTCIX | Deutsche Science | 0.70 | ||||
| KTCAX | Deutsche Science | 0.69 | ||||
| KTRAX | Deutsche Global | 0.59 | ||||
| KTRCX | Deutsche Global | 0.59 | ||||
| GCGGX | Deutsche Gnma | 0.34 | ||||
| SRMAX | Deutsche Short | 0.10 | ||||
| SRMCX | Deutsche Short | 0.10 | ||||
| SRMSX | Deutsche Short-term | 0.10 |
Other Information on Investing in Deutsche Mutual Fund
Deutsche Health financial ratios help investors to determine whether Deutsche Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deutsche with respect to the benefits of owning Deutsche Health security.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |